Julian Kamhieh‐Milz

MSC Therapies for COVID-19: Importance of Patient Coagulopathy, Thromboprophylaxis, Cell Product Quality and Mode of Delivery for Treatment Safety and Efficacy

Guido Moll, Norman Michael Drzeniek, Julian Kamhieh‐Milz et al. · Frontiers in Immunology · 2020 · 176 citations · Full text

High‐level serum B‐cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura

Florian Emmerich, Gürkan Bal, Alaa Barakat et al. · British Journal of Haematology · 2006 · 119 citations

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Jan Matthias Kruse, Annika Kurreck, Frédéric H Münch et al. · Critical Care · 2020 · 93 citations · Full text

Multi-Parameter Analysis of Biobanked Human Bone Marrow Stromal Cells Shows Little Influence for Donor Age and Mild Comorbidities on Phenotypic and Functional Properties

Anastazja Andrzejewska, Rusan Catar, Janosch Schoon et al. · Frontiers in Immunology · 2019 · 83 citations · Full text

Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression

Daniel Zickler, Christian Luecht, Kevin Willy et al. · Nephrology Dialysis Transplantation · 2017 · 65 citations